Vimarsana
Biggest News Aggregation in the World

Page 9 - Action Indicated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Action Indicated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Action Indicated Today - Breaking & Trending Today

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories - Vimarsana News

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Reuters 3 hrs ago (Repeats to additional subscribers with no changes to the text) By Dan Levine and Marisa Taylor May 5 (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. The unsigned report, filed April 8 in Lilly’s confidential emp...

Source: msn.com
Lilly hit by staff accusations, FDA scrutiny at Covid-19 drug factories - Vimarsana News

Lilly hit by staff accusations, FDA scrutiny at Covid-19 drug factories

Read more about Lilly hit by staff accusations, FDA scrutiny at Covid-19 drug factories on Business Standard. (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker's COVID-19

Lilly hit by staff accusations, FDA scrutiny at COVID drug factories - Vimarsana News

Lilly hit by staff accusations, FDA scrutiny at COVID drug factories

Message : Required fields (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker's COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. The unsigned report, filed April 8 in Lilly's confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. The complaint asserts that the executive, a top quality official at...

Whistleblower raises hygiene concerns from 2018 FDA inspection of Merck's Durham plant - Vimarsana News

Whistleblower raises hygiene concerns from 2018 FDA inspection of Merck's Durham plant

Whistleblower raises hygiene concerns from 2018 FDA inspection of Merck's Durham plant Zachery Eanes, The News & Observer (Raleigh, N.C.) Apr. 2—DURHAM — Inspection officials from the U.S. Food and Drug Administration improperly downgraded hygiene concerns in 2018 at Merck's Durham facility — a vaccine manufacturing plant that stands to play a key role in producing Johnson & Johnson's one-shot COVID-19 vaccines, according to a complaint filed by an FDA whistleblower. The whistleblower, a former FDA safety officer, wrote that he came away with serious public health concer...

Source: msn.com